News

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.
Once everyone’s had enough of injections, side effects, and the vast expense of GLP-1 drugs, it could be natural alternatives ...
GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...
Instant ramen maker Nissin Foods is leveraging the buzz around GLP-1s to launch in the US a trio of decadent tasting frozen ...
Dapiglutide, a novel GLP-1/GLP-2 receptor agonist, was associated with body weight reductions of up to 8.3% at 13 weeks for ...